Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
818 Constipation
clinical trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bellingham, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fresno, CA
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Oxnard, CA
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tulsa, OK
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Efficacy and Safety of SYN-010 in IBS-C
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Constipation Clinical Trial
Status: Upcoming
mi
from
Birmingham, AL
Click here to add this to my saved trials
Constipation Clinical Trial
Safety & Efficacy of the Vibrant Capsule in Aiding Patients With Functional Constipation
Status: Upcoming
Updated: 7/11/2016
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Constipation Clinical Trial
Safety & Efficacy of the Vibrant Capsule in Aiding Patients With Functional Constipation
Status: Upcoming
Updated: 7/11/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Constipation Clinical Trial
Safety & Efficacy of the Vibrant Capsule in Aiding Patients With Functional Constipation
Status: Upcoming
Updated: 7/11/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Gastroenterology, Other Clinical Trial
The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit
Status: Upcoming, Phase III
Updated: 3/4/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
HyGIeaCare Procedure for Chronic Constipation
Status: Upcoming
Updated: 11/4/2017
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Constipation Clinical Trial
Safety & Efficacy of the Vibrant Capsule in Aiding Patients With Functional Constipation
Status: Upcoming
Updated: 7/11/2016
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Constipation Predominant Irritable Bowel Syndrome Clinical Trial
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling, Phase II, III
Updated: 8/14/2013
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Edmonton,
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Lincoln, NE
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling, Phase I
Updated: 12/14/2017
mi
from
Copenhagen,
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling, Phase I
Updated: 12/14/2017
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling, Phase I
Updated: 12/14/2017
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling, Phase I
Updated: 12/14/2017
mi
from
Toledo, OH
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Carterville, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chelsea, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Pontiac, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Redmond, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sterling Heights, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Baker City, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, MI
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Homestead, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Newark, NJ
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Roanoke, VA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Scottdale, PA
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling, Phase I
Updated: 12/14/2017
mi
from
Dallas, TX
Click here to add this to my saved trials
Opioid Induced Constipation Clinical Trial
Naloxegol US PMR CV Safety.
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Wilmington, DE
Click here to add this to my saved trials
Constipation Clinical Trial
A Study to Assess the Efficacy and Safety of the Vibrant Capsule Administered 5 Times Per Week
Status: Enrolling
Updated: 1/11/2018
mi
from
Guntersville, AL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Garden City, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Great Bend, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Livonia, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
London, KY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ontario, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Caro, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Decatur, IL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
mi
from
Kelowna,
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fairfax, VA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Homestead, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling, Phase I
Updated: 12/14/2017
mi
from
Gaffney, SC
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling, Phase I
Updated: 12/14/2017
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling, Phase I
Updated: 12/14/2017
mi
from
Miami, FL
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling, Phase I
Updated: 12/14/2017
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Winchester, VA
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Henrico, VA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Efficacy and Safety of Plecanatide in Children 6 to
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Doral, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Brighton, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Caldwell, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Clarkston, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Macomb, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Macomb, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sedro-Woolley, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Swansea, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tawas City, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bolivar, MO
Click here to add this to my saved trials
Constipation Predominant Irritable Bowel Syndrome Clinical Trial
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling, Phase II, III
Updated: 8/14/2013
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling, Phase I
Updated: 12/14/2017
mi
from
Louisville, KY
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Stockbridge, GA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Efficacy and Safety of Plecanatide in Children 6 to
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Crowley, LA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Wyoming, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Brighton, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chelsea, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Clarkston, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Emmett, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Flint, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Hazleton, PA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Saginaw, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
West Branch, MI
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Constipation Predominant Irritable Bowel Syndrome Clinical Trial
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling, Phase II, III
Updated: 8/14/2013
mi
from
Boulder, CO
Click here to add this to my saved trials
Constipation Predominant Irritable Bowel Syndrome Clinical Trial
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling, Phase II, III
Updated: 8/14/2013
mi
from
Greensboro, NC
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Las Vegas, NV
Click here to add this to my saved trials
1 2 3 4 5 6 7 8